ACE and type 2 diabetes mellitus: However, after accounting for potential pleiotropy via changes in correlated indications, only ACE inhibitors demonstrated consistent evidence for a reduction in T2D risk (T2D MVMR OR = 0.86, 95% CI = 0.84, 0.89, p = 4.8 x 10−06 [IVW MR association]).